Default company panoramic image

Nano Discovery Inc.

Nano Discovery is dedicated to the development and commercialization of novel and proprietary high value molecular diagnostics for cancer.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Orlando, FL, USA
  • Currency USD
  • Founded October 2009
  • Website

Company Summary

Current prostate cancer diagnostic testing fails to clearly and accurately classify one third of tumors as indolent or aggressive, resulting in a significant number of over-treatment. Nano Discovery, Inc. is developing a novel, proprietary diagnostic test with the potential to identify aggressive prostate cancer from indolent tumor. Nano Discovery’s new test will improve patient outcomes and reduce costs to the healthcare system.


  • Default avatar
    MIchael Cerio
    Business Consultant

    Qun “Treen” Huo, Ph.D. is the founder of Nano Discovery. Dr. Huo is a tenured associate professor at University of Central Florida. During her faculty career, she has received many prestigious awards including CAREER award and NIRT award from the National Science Foundation. Dr. Huo is an expert in gold nanoparticle technology and cancer biomarker research. She has published more than 70 papers in peer-reviewed scientific journals.

  • Default avatar
    Qun Treen Huo
    Executive Vice President and CSO

    Michael Cerio is acting as business consultant. Previously he was Senior Director of Business Development for Genzyme Corporation and led licensing, commercial strategy and M&A activities for the Genzyme Genetics diagnostic testing business unit.